Quarterly report pursuant to Section 13 or 15(d)

Going Concern and Management's Plans (Details)

v3.23.3
Going Concern and Management's Plans (Details) - USD ($)
 3 Months Ended 9 Months Ended
Aug. 09, 2023
Apr. 05, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Going Concern and Management's Plans (Details) [Line Items]                      
Accumulated deficit     $ (126,116,552)           $ (126,116,552)   $ (107,408,545)
Working capital deficit     1,435,947           1,435,947    
Net losses     $ (10,265,760) $ (3,680,169) $ (4,762,078) $ (21,486,978) $ 2,939,284 $ 1,563,713 (18,708,007) $ (16,983,981)  
Cash used in operating activities                 $ (8,762,209) $ (9,200,830)  
Common stock, pre-funded warrants to purchase (in Shares) 667,000                    
common stock issued (in Shares)     6,738,456           6,738,456   3,746,906
Gross Proceeds $ 3,000,000 $ 3,000,000                  
Common Stock [Member]                      
Going Concern and Management's Plans (Details) [Line Items]                      
Net losses            
Common stock, pre-funded warrants to purchase (in Shares)   400,000 666,925 [1] 400,000 [2]   175,000 [3]          
April 2023 Pre-Funded Warrants [Member]                      
Going Concern and Management's Plans (Details) [Line Items]                      
common stock issued (in Shares) 3,900,000 1,200,000                  
April 2023 Common Warrants [Member]                      
Going Concern and Management's Plans (Details) [Line Items]                      
common stock issued (in Shares)   1,600,000                  
August 2023 Common Warrants [Member]                      
Going Concern and Management's Plans (Details) [Line Items]                      
common stock issued (in Shares) 4,600,000                    
[1] Consists of $2,999,605 of gross proceeds from the August 2023 Offering; gross proceeds of $272,106 are related to common shares issued (with related placement agent fees of $26,758), gross proceeds of $1,449,470 are related to pre-funded warrants issued (with related placement agent fees of $142,538) and gross proceeds of $1,278,029 are related to common warrants issued (with related placement agent fees of $125,679). At the end of the period, 663,460 August 2023 pre-funded warrants were exercised for proceeds of $66.
[2] Consists of $2,999,882 of gross proceeds from the April 2023 Offering; gross proceeds of $421,527 are related to common shares issued (with related placement agent fees of $39,343), gross proceeds of $1,233,564 are related to pre-funded warrants issued (with related placement agent fees of $115,134) and gross proceeds of $1,344,791 are related to common warrants issued (with related placement agent fees of $125,516). At the end of the current period, all 1,170,680 April 2023 pre-funded warrants were exercised for proceeds of $117.
[3] Consists of $6,499,737 of gross proceeds from the July 2022 Offering; gross proceeds of $3,710,000 are related to the common shares and common warrants issued and includes $302,510 in related placement agent fees and other offering costs, and $2,789,737 in gross proceeds are in connection with the pre-funded warrants and includes $227,472 in related placement agent fees and other offering costs. At the end of the period, 1,547,076 July 2022 pre-funded warrants were exercised for proceeds of $155.